Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS - Yahoo Finance finance.yahoo.com Submitted by yahooentertainment6306 on March 15, 2024 at 7:54 PM in business No comments 33